Effect of Herbal tablet Pinak on HIV, Hepatitis B and HEPATITIS C corona viruses

A PHASE III, PROSPECTIVE, RANDOMIZED, MULTICENTRIC, MULTIDOSE, TWO TREATMENT, PARALLEL, COMPARATIVE CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PINAK TABLET AGAINST CORONA VIRUSES ADMINISTERED ORALLY AS ADJUVANT TO ART IN HUMAN ADULT PATIENTS WITH AIDS, HEPATITIS B AND HEPATITIS C

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/10/037309

Enrollment

Registered

2021-10-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B181- Chronic viral hepatitis B withoutdelta-agent Health Condition 2: B182- Chronic viral hepatitis C Health Condition 3: B20- Human immunodeficiency virus [HIV]disease

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed Patients of AIDS Diagnosed Patients of Hepatitis B Diagnosed Patients of Hepatitis C Subjects voluntarily providing written informed consent and willing to give regular follow-up

Exclusion criteria

Exclusion criteria: Following death prone toxic cases will be excluded Subjects with life expectancy less than 1 year Associated serious diseases Patients in ICU Patients with ventilator Patients with renal failure All pediatrics cases All pregnant cases All lactating cases LFT more than 3 times upper limit of normal Hypersensitivity to any of the ingredients of study product

Design outcomes

Primary

Measure	Time frame
To study the results of Pinak in the treatment of AIDS and Hepatitis B and C To study comparative clinical recovery with Pinak To study the effects of addition of Pinak on viral loads of the patients in AIDS HB and Hc To study the effects on CD4 counts of the patients due to Pinak in AIDSTimepoint: Baseline Day 31 Day 61 Day 91 Day181	—

Secondary

Measure	Time frame
To study the effect of Pinak on resistance developing to the drugs To study the effects of Pinak on secondary infections and fibrosis of Liver and cancer development To study the possible cure of AIDS and Hepatitis B and Hepatitis C Timepoint: Day 61 Day 91 Day 181	—

Countries

India

Contacts

Public ContactDr Pandurang Shrirang Pawar

Bhagyashri Clinic

drpandurangpawar@gmail.com9881240101

Outcome results